The authors compared second-generation with third-generation carbonic anhydrase IX targeted CAR constructs and investigated the anti-tumor effect of CAR-T cells with different CD4/CD8 proportions in vitro and in vivo.
[Molecular Therapy Oncolytics]
Sorry, but the selected Zotpress account can't be found.
